Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on May 19, 2026 by admin

Zero-shot de novo peptide sequencing with open posttranslational modification discovery

Nature Biotechnology, Published online: 19 May 2026; doi:10.1038/s41587-026-03116-1

RNovA is an open-search de novo peptide sequencing model.

CategoriesUncategorized TagsBiotech, Genomics, News Approved

Post navigation

Previous PostPrevious A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism
Next PostNext Editorial: The role of self-perception in mental health: current insights on self-esteem and self-schemas
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.